Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease vascular disease
Symptom |diabetes
Sentences 526
PubMedID- 20550690 The risk factors were presented in the questionnaire in the following order: higher age, hyperlipidemia, diabetes, a family history of cardiovascular disease, atrial fibrillation, hypertension, overweight, regular physical exercise, excessive alcohol consumption, previous stroke/tia, carotid stenosis, smoking and ischaemic heart disease.
PubMedID- 23951331 This prospective cohort study demonstrates the value of ldl particle size measurements in the prediction of changes in metabolic status and cardiovascular disease in patients with diabetes or prediabetes.
PubMedID- 20210989 In a more recent controlled study performed in our center 6, it was found that blood flow alterations (stenoses and/or occlusions) demonstrated in temporal arteries with doppler ultrasonography are neither specific nor sensitive for gca, since these findings were equally common among elderly individuals or patients with macrovascular disease associated with diabetes mellitus or stroke, due to the temporal artery atherosclerotic changes.
PubMedID- 22285702 We investigated the effect of rhr on the incidence of type 2 diabetes mellitus (t2dm) in patients with clinically manifest vascular diseases.
PubMedID- 25708055 This study aimed to assess the effects of active and passive smoking exposure on the development of cardiovascular disease in patients with type 2 diabetes mellitus.
PubMedID- 25990316 vascular disease in diabetes mellitus.
PubMedID- 26173772 Confounders for this association were age, ethnicity, season, sun exposure, diabetes duration, presence of cardiovascular disease, egfr, alkaline phosphatase and ldl cholesterol.
PubMedID- 25922835 Resistin has been recognised as an adipocytokine positively correlated with insulin resistance and type 2 diabetes and is predictive of cardiovascular disease .
PubMedID- 22906083 Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care.
PubMedID- 23323191 The pathophysiology underlying cognitive change in type 2 diabetes is examined with reference to vascular disease, hypoglycaemia, inflammation and insulin levels.
PubMedID- 25685383 Trends in the risk for cardiovascular disease among adults with diabetes in oman.
PubMedID- 23160724 The risk of death from cardiovascular disease among people with diabetes who reported a moderate to high physical activity level was similar to inactive people without diabetes.
PubMedID- 24354901 Model 3: model 2 plus adjustment for medications (for hypertension, diabetes, and dyslipidemia), history of stroke or cardiovascular disease, daily alcohol consumption (versus infrequent/no alcohol consumption), and regular exercise (≥30 min exercise per session >2 times/week versus infrequent exercise).
PubMedID- 25877139 Objective: to investigate if a six-year intensive lifestyle intervention in people with pre-diabetes lead to reduction of cardiovascular events and cardiovascular disease (cvd) mortality in subsequent 23 years.
PubMedID- 26244041 A recent review identified twelve risk equations for the prediction of cardiovascular disease in subjects with type 2 diabetes mellitus (t2dm) 6.
PubMedID- 20186491 We then discuss the implications of these studies for current management and for new approaches for the prevention and treatment of cardiovascular disease in patients with diabetes mellitus.
PubMedID- 25927959 Background: hyperglycemia has been recognized as a primary factor in endothelial barrier dysfunction and in the development of micro- and macrovascular diseases associated with diabetes, but the underlying biochemical mechanisms remain elusive.
PubMedID- 22184101 Study selection: a study was eligible when it described the development, validation or impact assessment of a model that was constructed to predict the occurrence of cardiovascular disease in people with type 2 diabetes, or when the model was designed for use in the general population but included diabetes as a predictor.
PubMedID- 22851545 Background: endothelial damage and dysfunction are crucial mediators that link diabetes mellitus with atherosclerotic cardiovascular disease.
PubMedID- 26292807 Patients’ characteristics including metabolic co-morbidities and leucocyte counts as well as treatment characteristics are summarized in table 1. comorbidities included diabetes in 15.1 % of patients, cardiovascular disease in 34.6 % and hypertension in 45.7 %.
PubMedID- 23275224 While cardiovascular diseases in diabetes are macrovascular in origin, retinopathy is microvascular, and each has distinct and different set of major etiological factors.
PubMedID- 21291555 Apart from the combination of cardiovascular disease with comorbid diabetes reported by 60.2%, arthritis was consistently among the most commonly reported comorbid condition, being reported by a third of people with the index conditions.
PubMedID- 25848912 The association between circulating mmps and macrovascular disease in patients with type 1 diabetes has not been investigated, while studies on the associations between mmp levels and microvascular complications seem contradictory.
PubMedID- 19754853 Methods: cardiovascular disease patients with diabetes mellitus (group a, n = 14) and nondiabetic patients with cvd only (group b, n = 10) took atorvastatin 80 mg per day for a period of 8-10 weeks.
PubMedID- 22389337 Since diabetes increases the risk of cardiovascular disease, for example, the impact of interventions for the treatment of hyperglycaemia in reducing this risk should be assessed.
PubMedID- 26429401 Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in sweden: a nationwide, matched, observational cohort study.
PubMedID- 22665334 As an example, cpgs for cardiovascular diseases in diabetes mellitus have been developed.24 these cpgs contain detailed practical instructions for management of cardiovascular diseases in diabetic patients.24 some studies have reported that cpgs can improve the health outcomes of patients in terms of in-hospital mortality or los and concluded that cpgs were a significant independent predictor of clinical outcomes of patients.25,26 therefore, we think that the preparation and institution of cpgs for bleeding peptic ulcers with comorbid diabetes mellitus would be a promising policy implementation for improving the short-term clinical outcomes of these patients.
PubMedID- 22809064 Both ra and diabetes increase the risk of cardiovascular disease (cvd), yet understanding of how comorbid ra impacts the receipt of guideline-based diabetes care is limited.
PubMedID- 26003174 The pathophysiology of vascular disease in diabetes involves abnormalities in endothelial and vsmcs, and alterations in platelet function .
PubMedID- 20415560 Vitamin e reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype.
PubMedID- 21963020 Preliminary evidence in support of fruit intake for the prevention of cardiovascular disease in patients with type 2 diabetes mellitus (t2dm) is still limited.
PubMedID- 23049260 Jablecka et al treated 38 patients who had peripheral vascular disease with type ii diabetes using l-arginine.26 the total study population was 50 (38 subjects and twelve controls).
PubMedID- 21470634 Background: accelerated cardiovascular disease in patients with type i diabetes (tid) is a well-described condition and serious clinical obstacle.
PubMedID- 21270199 Thus, ages may explain, in part, the increased cardiovascular disease and mortality attributable to type 1 diabetes and constitute a specific target for treatment in these patients.
PubMedID- 22844422 Although most early studies so far have been concerned by the concept that factors secreted from the gut endocrine system participate in the regulation of gastrointestinal functions, growing evidence underlines their functions in metabolic pathways and in the pathophysiology of various metabolic diseases, including obesity, insulin resistance and diabetes, which lead to cardiovascular diseases.
PubMedID- 25899452 Statins have been shown to be beneficial in reducing cardiovascular disease (cvd) in patients with type 2 diabetes , but it remains unclear whether these effects can be explained by their lipid-lowering effects only.
PubMedID- 21933841 Purpose: to evaluate myocardial microvascular disease in patients with type 2 diabetes mellitus (dm) using myocardial contrast echocardiography (mce) and to report on its diagnostic accuracy using single photon emission tomography (spect) as reference test.
PubMedID- 23250799 However, as diabetes may be associated with macrovascular disease prior to esrd, adjusting for diabetes may control for some residual confounding that may have existed in the overall model.
PubMedID- 21990060 Cardiovascular disease patients with diabetes mellitus type 2.
PubMedID- 24059905 The risk factors for ischemic stroke include aging, hypertension, diabetes, smoking, history of cardiovascular diseases, atrial fibrillation, and left ventricular hypertrophy .
PubMedID- 22711281 Most diabetes-related complications and causes of death arise from cardiovascular disease and end-stage renal disease.
PubMedID- 24147047 To stratify the subjects, comorbid conditions and other risk factors such as congestive heart failure, hypertension, age ≥75, diabetes, history of stroke, vascular disease, age 65–74, and sex category were taken into account according to the cha2ds2-vasc or chads2 scheme criteria .
PubMedID- 22422191 Mortality of cardiovascular diseases in patients with type 1 diabetes is increased 2- to 20-fold compared to non-diabetic individuals.
PubMedID- 24920930 Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus.
PubMedID- 22322078 To date, the drug approach to prevention of microvascular disease starting with pre-diabetes has not been evaluated.
PubMedID- 24855344 Several large-scale, prospective, randomized trials have documented that lowering glycemic levels can prevent the development of microvascular disease in people with type 2 diabetes mellitus (t2dm).
PubMedID- 24349248 As described above, the decrease of serum bfgf appears in infarction, stroke and peripheral vascular disease associated with diabetes .
PubMedID- 24728837 The presence of cardiovascular diseases was significantly associated with diabetes mellitus in patients with copd.
PubMedID- 22647032 The pathophysiology of vascular disease in diabetes involves abnormalities in endothelial cells, vascular smooth muscle cells, and monocytes.
PubMedID- 22440125 Microalbuminuria is one of the strongest predictors of both adverse renal and cardiovascular disease (cvd) outcomes in patients with type 2 diabetes mellitus.

Page: 1 2 3 4 5 6 7 8 9 10 11